JVMAX | WFMDX | JVMAX / WFMDX | |
Total Expense Ratio | 1.10 | 1.05 | 105% |
Annual Report Gross Expense Ratio | 1.11 | 1.05 | 106% |
Fund Existence | 28 years | 21 years | - |
Gain YTD | 9.048 | 3.593 | 252% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.7B | 13.3B | 178% |
Annual Yield % from dividends | 0.55 | 0.97 | 57% |
Returns for 1 year | -6.10 | -7.04 | 87% |
Returns for 3 years | 22.95 | 13.16 | 174% |
Returns for 5 years | 43.73 | 32.69 | 134% |
Returns for 10 years | 44.99 | 60.22 | 75% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LMBS | 50.16 | 0.04 | +0.08% |
First Trust Low Duration Oppos ETF | |||
SVAL | 32.77 | N/A | +0.01% |
iShares US Small Cap Value Factor ETF | |||
QCON | 47.92 | N/A | N/A |
American Century Quality Convertible Securities ETF | |||
PMBS | 49.97 | -0.01 | -0.03% |
PIMCO Mortgage-Backed Securities Act ETF | |||
HQL | 16.50 | -0.08 | -0.48% |
abrdn Life Sciences Investors |